<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress/2.0.5" -->
<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>

<channel>
	<title>Medical Journal, Health Articles</title>
	<link>http://rxjournals.com</link>
	<description>Health and medical news to help you live a better life</description>
	<pubDate>Sat, 05 Jul 2008 15:00:00 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.0.5</generator>
	<language>en</language>
			<item>
		<title>Hepatic Diseases Treated With Stem Cells From Umbilical Cord</title>
		<link>http://rxjournals.com/hepatic-diseases-treated-with-stem-cells-from-umbilical-cord/</link>
		<comments>http://rxjournals.com/hepatic-diseases-treated-with-stem-cells-from-umbilical-cord/#comments</comments>
		<pubDate>Sat, 05 Jul 2008 15:00:00 +0000</pubDate>
		<dc:creator></dc:creator>
		
	<dc:subject>Liver Disease</dc:subject>
	<!-- AutoMeta Start -->
	<category></category>
	<!-- AutoMeta End -->
	
		<guid isPermaLink="false">http://rxjournals.com/hepatic-diseases-treated-with-stem-cells-from-umbilical-cord/</guid>
		<description><![CDATA[Scientists of the University of Granada, in collaboration with the University of Leon, have confirmed that stem cells from human umbilical cord blood can be an appropriate therapy for the treatment of hepatic diseases such as hepatitis, and therefore mean an effective alternative to bone marrow.
Original post by Writhe Safely
]]></description>
			<content:encoded><![CDATA[<p>Scientists of the University of Granada, in collaboration with the University of Leon, have confirmed that stem cells from human umbilical cord blood can be an appropriate therapy for the treatment of hepatic diseases such as hepatitis, and therefore mean an effective alternative to bone marrow.Original post by Writhe Safely
</p>
]]></content:encoded>
			<wfw:commentRss>http://rxjournals.com/hepatic-diseases-treated-with-stem-cells-from-umbilical-cord/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Beating Depression For Cancer Patients</title>
		<link>http://rxjournals.com/beating-depression-for-cancer-patients/</link>
		<comments>http://rxjournals.com/beating-depression-for-cancer-patients/#comments</comments>
		<pubDate>Sat, 05 Jul 2008 15:00:00 +0000</pubDate>
		<dc:creator></dc:creator>
		
	<dc:subject>Depression</dc:subject>
	<!-- AutoMeta Start -->
	<category></category>
	<!-- AutoMeta End -->
	
		<guid isPermaLink="false">http://rxjournals.com/beating-depression-for-cancer-patients/</guid>
		<description><![CDATA[A new treatment programme for cancer patients with clinical depression can significantly boost their quality of life according to new research published in the Lancet.   Cancer Research UK scientists devised the treatment programme which offers patients one-to-one sessions with specially trained cancer nurses to help them manage their depression more effectively.
Original post by [...]]]></description>
			<content:encoded><![CDATA[<p>A new treatment programme for cancer patients with clinical depression can significantly boost their quality of life according to new research published in the Lancet.   Cancer Research UK scientists devised the treatment programme which offers patients one-to-one sessions with specially trained cancer nurses to help them manage their depression more effectively.Original post by Allergy News From Medical News Today
</p>
]]></content:encoded>
			<wfw:commentRss>http://rxjournals.com/beating-depression-for-cancer-patients/feed/</wfw:commentRss>
		</item>
		<item>
		<title>French EU Presidency Makes Fight Against Alzheimer&#8217;s Disease A Priority</title>
		<link>http://rxjournals.com/french-eu-presidency-makes-fight-against-alzheimers-disease-a-priority/</link>
		<comments>http://rxjournals.com/french-eu-presidency-makes-fight-against-alzheimers-disease-a-priority/#comments</comments>
		<pubDate>Sat, 05 Jul 2008 12:00:00 +0000</pubDate>
		<dc:creator></dc:creator>
		
	<dc:subject>Alzheimers Disease</dc:subject>
	<!-- AutoMeta Start -->
	<category></category>
	<!-- AutoMeta End -->
	
		<guid isPermaLink="false">http://rxjournals.com/french-eu-presidency-makes-fight-against-alzheimers-disease-a-priority/</guid>
		<description><![CDATA[At a joint press conference with Commission President Barroso on 2 July 2008 highlighting the priorities of the French Presidency, French President Nicolas Sarkozy announced the commitment of the French Presidency to the development of a European Alzheimer&#8217;s Plan. He stressed that the French Presidency would be working with all its partners to find concrete [...]]]></description>
			<content:encoded><![CDATA[<p>At a joint press conference with Commission President Barroso on 2 July 2008 highlighting the priorities of the French Presidency, French President Nicolas Sarkozy announced the commitment of the French Presidency to the development of a European Alzheimer&#8217;s Plan. He stressed that the French Presidency would be working with all its partners to find concrete solutions for this scourge which affects millions of Europeans.Original post by Allergy News From Medical News Today
</p>
]]></content:encoded>
			<wfw:commentRss>http://rxjournals.com/french-eu-presidency-makes-fight-against-alzheimers-disease-a-priority/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Vaccine To Prevent Kidney Cancer Recurrence Not Shown To Be Effective</title>
		<link>http://rxjournals.com/vaccine-to-prevent-kidney-cancer-recurrence-not-shown-to-be-effective/</link>
		<comments>http://rxjournals.com/vaccine-to-prevent-kidney-cancer-recurrence-not-shown-to-be-effective/#comments</comments>
		<pubDate>Sat, 05 Jul 2008 08:00:00 +0000</pubDate>
		<dc:creator></dc:creator>
		
	<dc:subject>Cancer</dc:subject>
	<!-- AutoMeta Start -->
	<category></category>
	<!-- AutoMeta End -->
	
		<guid isPermaLink="false">http://rxjournals.com/vaccine-to-prevent-kidney-cancer-recurrence-not-shown-to-be-effective/</guid>
		<description><![CDATA[  A randomized trial that studied the impact of the new vitespen vaccine,  administered after surgery for kidney cancer, failed to demonstrate an  increase in recurrence-free survival (RFS). More research is needed,  according to the study authors, in order to know whether the vaccine  can increase RFS if given to [...]]]></description>
			<content:encoded><![CDATA[<p>  A randomized trial that studied the impact of the new vitespen vaccine,  administered after surgery for kidney cancer, failed to demonstrate an  increase in recurrence-free survival (RFS). More research is needed,  according to the study authors, in order to know whether the vaccine  can increase RFS if given to patients during the early stages of the  disease.Original post by Allergy News From Medical News Today
</p>
]]></content:encoded>
			<wfw:commentRss>http://rxjournals.com/vaccine-to-prevent-kidney-cancer-recurrence-not-shown-to-be-effective/feed/</wfw:commentRss>
		</item>
		<item>
		<title>KAI-1 Able To Distinguish Chromophobe Renal Cancers From Oncocytoma</title>
		<link>http://rxjournals.com/kai-1-able-to-distinguish-chromophobe-renal-cancers-from-oncocytoma/</link>
		<comments>http://rxjournals.com/kai-1-able-to-distinguish-chromophobe-renal-cancers-from-oncocytoma/#comments</comments>
		<pubDate>Sat, 05 Jul 2008 08:00:00 +0000</pubDate>
		<dc:creator></dc:creator>
		
	<dc:subject>Cancer</dc:subject>
	<!-- AutoMeta Start -->
	<category></category>
	<!-- AutoMeta End -->
	
		<guid isPermaLink="false">http://rxjournals.com/kai-1-able-to-distinguish-chromophobe-renal-cancers-from-oncocytoma/</guid>
		<description><![CDATA[ORLANDO, FL (UroToday.com) - (Reported from the Annual Meeting of the American Urological Association) Researchers showed that KAI-1 can differentiate chromophobe renal cancers from oncocytoma.     Papillary renal cancer with clear cell components is worse than pure papillary tumors.     There was a general trend toward watching small renal [...]]]></description>
			<content:encoded><![CDATA[<p>ORLANDO, FL (UroToday.com) - (Reported from the Annual Meeting of the American Urological Association) Researchers showed that KAI-1 can differentiate chromophobe renal cancers from oncocytoma.     Papillary renal cancer with clear cell components is worse than pure papillary tumors.     There was a general trend toward watching small renal masses rather than surgery. Small renal tumors that are destined to be metastatic have a growth rate of 0.74cm/year compared to 0.Original post by Allergy News From Medical News Today
</p>
]]></content:encoded>
			<wfw:commentRss>http://rxjournals.com/kai-1-able-to-distinguish-chromophobe-renal-cancers-from-oncocytoma/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Bladder Cancer - Reported From The Annual Meeting Of The American Urological Association</title>
		<link>http://rxjournals.com/bladder-cancer-reported-from-the-annual-meeting-of-the-american-urological-association/</link>
		<comments>http://rxjournals.com/bladder-cancer-reported-from-the-annual-meeting-of-the-american-urological-association/#comments</comments>
		<pubDate>Sat, 05 Jul 2008 08:00:00 +0000</pubDate>
		<dc:creator></dc:creator>
		
	<dc:subject>Cancer</dc:subject>
	<!-- AutoMeta Start -->
	<category></category>
	<!-- AutoMeta End -->
	
		<guid isPermaLink="false">http://rxjournals.com/bladder-cancer-reported-from-the-annual-meeting-of-the-american-urological-association/</guid>
		<description><![CDATA[ORLANDO, FL (UroToday.com) - Abstract 1791 showed the importance of a repeat TURBT for T1 grade 3 tumors. If there is no residual tumor (NRT) on the repeat TURBT patients do much better than if there is residual tumor (SRT).     NRT - Recurrence 17% - Progression 10% - DFS 78%  [...]]]></description>
			<content:encoded><![CDATA[<p>ORLANDO, FL (UroToday.com) - Abstract 1791 showed the importance of a repeat TURBT for T1 grade 3 tumors. If there is no residual tumor (NRT) on the repeat TURBT patients do much better than if there is residual tumor (SRT).     NRT - Recurrence 17% - Progression 10% - DFS 78%  SRT - Recurrence 45% - Progression 23% - DFS 50%      Abstract 1695 showed that 60% of all bladder cancer deaths occur within the first 2 years of diagnosis.Original post by Allergy News From Medical News Today
</p>
]]></content:encoded>
			<wfw:commentRss>http://rxjournals.com/bladder-cancer-reported-from-the-annual-meeting-of-the-american-urological-association/feed/</wfw:commentRss>
		</item>
		<item>
		<title>New Depression Treatment For Cancer Patients Shows Promise</title>
		<link>http://rxjournals.com/new-depression-treatment-for-cancer-patients-shows-promise/</link>
		<comments>http://rxjournals.com/new-depression-treatment-for-cancer-patients-shows-promise/#comments</comments>
		<pubDate>Sat, 05 Jul 2008 08:00:00 +0000</pubDate>
		<dc:creator></dc:creator>
		
	<dc:subject>Cancer</dc:subject>
	<!-- AutoMeta Start -->
	<category></category>
	<!-- AutoMeta End -->
	
		<guid isPermaLink="false">http://rxjournals.com/new-depression-treatment-for-cancer-patients-shows-promise/</guid>
		<description><![CDATA[  An article published in The Lancet finds that  cancer patients who received a care package called &#8220;Depression Care for  People with Cancer&#8221; (DCPC) had lower levels of depression than those  who received the usual care (antidepressants and mental health services  recommended by the cancer team).
Original post by Allergy News [...]]]></description>
			<content:encoded><![CDATA[<p>  An article published in The Lancet finds that  cancer patients who received a care package called &#8220;Depression Care for  People with Cancer&#8221; (DCPC) had lower levels of depression than those  who received the usual care (antidepressants and mental health services  recommended by the cancer team).Original post by Allergy News From Medical News Today
</p>
]]></content:encoded>
			<wfw:commentRss>http://rxjournals.com/new-depression-treatment-for-cancer-patients-shows-promise/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Promising Hematologists Begin Year-Long Program To Pursue Careers In Clinical Hematology Research</title>
		<link>http://rxjournals.com/promising-hematologists-begin-year-long-program-to-pursue-careers-in-clinical-hematology-research/</link>
		<comments>http://rxjournals.com/promising-hematologists-begin-year-long-program-to-pursue-careers-in-clinical-hematology-research/#comments</comments>
		<pubDate>Sat, 05 Jul 2008 08:00:00 +0000</pubDate>
		<dc:creator></dc:creator>
		
	<dc:subject>Cancer</dc:subject>
	<!-- AutoMeta Start -->
	<category></category>
	<!-- AutoMeta End -->
	
		<guid isPermaLink="false">http://rxjournals.com/promising-hematologists-begin-year-long-program-to-pursue-careers-in-clinical-hematology-research/</guid>
		<description><![CDATA[Twenty hematology and hematology/oncology fellows and junior faculty will begin a unique year-long education and mentoring program this summer as part of the American Society of Hematology (ASH) Clinical Research Training Institute.    Each year, the Clinical Research Training Institute provides aspiring hematologists with the necessary tools to begin careers in clinical research.
Original [...]]]></description>
			<content:encoded><![CDATA[<p>Twenty hematology and hematology/oncology fellows and junior faculty will begin a unique year-long education and mentoring program this summer as part of the American Society of Hematology (ASH) Clinical Research Training Institute.    Each year, the Clinical Research Training Institute provides aspiring hematologists with the necessary tools to begin careers in clinical research.Original post by Allergy News From Medical News Today
</p>
]]></content:encoded>
			<wfw:commentRss>http://rxjournals.com/promising-hematologists-begin-year-long-program-to-pursue-careers-in-clinical-hematology-research/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Ritalin-style Drug Set For Wider Role In Adult Mental Illness</title>
		<link>http://rxjournals.com/ritalin-style-drug-set-for-wider-role-in-adult-mental-illness/</link>
		<comments>http://rxjournals.com/ritalin-style-drug-set-for-wider-role-in-adult-mental-illness/#comments</comments>
		<pubDate>Sat, 05 Jul 2008 08:00:00 +0000</pubDate>
		<dc:creator></dc:creator>
		
	<dc:subject>Depression</dc:subject>
	<!-- AutoMeta Start -->
	<category></category>
	<!-- AutoMeta End -->
	
		<guid isPermaLink="false">http://rxjournals.com/ritalin-style-drug-set-for-wider-role-in-adult-mental-illness/</guid>
		<description><![CDATA[  A significant number of adults with unresolved depression, anxiety or addiction may actually have Attention Deficit Hyperactivity Disorder (ADHD), a condition that has been widely considered to resolve in late adolescence.
Original post by Allergy News From Medical News Today
]]></description>
			<content:encoded><![CDATA[<p>  A significant number of adults with unresolved depression, anxiety or addiction may actually have Attention Deficit Hyperactivity Disorder (ADHD), a condition that has been widely considered to resolve in late adolescence.Original post by Allergy News From Medical News Today
</p>
]]></content:encoded>
			<wfw:commentRss>http://rxjournals.com/ritalin-style-drug-set-for-wider-role-in-adult-mental-illness/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Prozac Gene Test Good For Patients, Royal College Of Psychiatrists</title>
		<link>http://rxjournals.com/prozac-gene-test-good-for-patients-royal-college-of-psychiatrists/</link>
		<comments>http://rxjournals.com/prozac-gene-test-good-for-patients-royal-college-of-psychiatrists/#comments</comments>
		<pubDate>Sat, 05 Jul 2008 08:00:00 +0000</pubDate>
		<dc:creator></dc:creator>
		
	<dc:subject>Depression</dc:subject>
	<!-- AutoMeta Start -->
	<category></category>
	<!-- AutoMeta End -->
	
		<guid isPermaLink="false">http://rxjournals.com/prozac-gene-test-good-for-patients-royal-college-of-psychiatrists/</guid>
		<description><![CDATA[People who suffer depression that does not respond to medication could be treated successfully if a simple genetic blood test was made more widely available in the UK.      Four out of 10 people with depression have a genetic abnormality that prevents them responding to anti-depressant medication, according to research presented [...]]]></description>
			<content:encoded><![CDATA[<p>People who suffer depression that does not respond to medication could be treated successfully if a simple genetic blood test was made more widely available in the UK.      Four out of 10 people with depression have a genetic abnormality that prevents them responding to anti-depressant medication, according to research presented at the Royal College of Psychiatrists&#8217; Annual Meeting in London this week.Original post by Allergy News From Medical News Today
</p>
]]></content:encoded>
			<wfw:commentRss>http://rxjournals.com/prozac-gene-test-good-for-patients-royal-college-of-psychiatrists/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>
